$367.2 M

OXFD Mkt cap, 14-Dec-2018

£77.6 M

Oxford Immunotec Revenue FY, 2017
Oxford Immunotec Gross profit (FY, 2017)42.4 M
Oxford Immunotec Gross profit margin (FY, 2017), %54.6%
Oxford Immunotec Net income (FY, 2017)-25.8 M
Oxford Immunotec EBITDA (FY, 2017)-38.4 M
Oxford Immunotec EBIT (FY, 2017)-40.8 M
Oxford Immunotec Cash, 31-Dec-201768 M

Oxford Immunotec Revenue

Oxford Immunotec revenue was £77.65 m in FY, 2017

Embed Graph

Oxford Immunotec Income Statement

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

12.1m25.5m36.6m48.6m64.8m77.6m

Revenue growth, %

44%27%

Cost of goods sold

7.3m12.2m17.8m22.9m29.6m35.2m

Gross profit

4.8m13.3m18.9m25.7m35.2m42.4m

Gross profit Margin, %

40%52%52%53%54%55%

Operating expense total

12.5m17.7m34.9m44.4m54.2m83.3m

EBITDA

(7.6m)(14.8m)(17.0m)(16.7m)(38.4m)

EBITDA margin, %

(63%)(40%)(35%)(26%)(50%)

EBIT

(7.6m)(4.5m)(16.0m)(18.7m)(19.0m)(40.8m)

EBIT margin, %

(63%)(18%)(44%)(38%)(29%)(53%)

Pre tax profit

(8.8m)(5.6m)(16.3m)(18.8m)(19.3m)(23.4m)

Income tax expense

88.3k(60.5k)(113.9k)(113.1k)2.6m(2.3m)

Net Income

(8.7m)(5.7m)(16.4m)(19.0m)(16.7m)(25.8m)

Oxford Immunotec Balance Sheet

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

7.8m50.6m37.4m64.9m44.5m68.0m

Accounts Receivable

3.2m3.1m5.0m5.5m10.0m12.8m

Inventories

1.8m3.6m4.8m5.5m5.7m7.7m

Current Assets

13.5m58.8m49.2m78.7m62.0m90.8m

PP&E

1.3m1.9m3.4m4.9m5.5m6.0m

Goodwill

217.7k2.0m1.5m

Total Assets

14.9m61.0m54.6m85.1m94.3m108.6m

Accounts Payable

1.0m1.5m1.8m2.9m2.4m5.2m

Current Liabilities

4.9m7.3m8.6m12.0m14.6m18.0m

Non-Current Liabilities

83.6k564.9k1.2m1.3m24.5m25.7m

Total Liabilities

5.0m7.9m9.8m13.3m39.1m43.7m

Additional Paid-in Capital

4.8m123.6k142.0k188.2k183.1k202.6k

Retained Earnings

(8.7m)(5.7m)(16.4m)(19.0m)(16.7m)(25.8m)

Total Equity

9.9m53.1m44.8m71.8m55.3m64.9m

Financial Leverage

1.5 x1.1 x1.2 x1.2 x1.7 x1.7 x

Oxford Immunotec Cash Flow

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(8.7m)(5.7m)(16.4m)(19.0m)(16.7m)(25.8m)

Cash From Operating Activities

(3.7m)(15.4m)(12.8m)(16.5m)(2.9m)

Cash From Financing Activities

46.5m(111.7k)41.6m21.9m29.8m

Net Change in Cash

41.6m(19.2m)26.3m(17.2m)23.2m

Income Taxes Paid

(60.5k)(113.9k)(108.0k)

Oxford Immunotec Ratios

GBPY, 2017

Revenue/Employee

173.2k

Financial Leverage

1.7 x
Report incorrect company information

Oxford Immunotec Employee Rating

2.757 votes
Culture & Values
2.7
Work/Life Balance
2.8
Senior Management
2.6
Salary & Benefits
3.7
Career Opportunities
2.6
Source